DCP Logo
  • Home
  • About
    • DCP program
    • DCP program history
    • Structural Genomic Consortium
    • Probe contributions
  • Show Probes
    • All
    • Kinase
    • GPCR
    • Ion channel
    • Epigenetics
    • Other enzymes
    • Other targets
  • Order set
  • Download
  • Information
    • FAQ
    • Probe resources
    • Donate probes
    • Contact
    • Funding
    • Update history
All probes Probe criteria Further information Usage Order Properties Structure Compound analysis Potency Selectivity Phenotypic data Data download
  • Probe criteria
  • Further information
  • Usage
  • Order
  • Properties
  • Structure
  • Compound analysis
  • Potency
  • Selectivity
  • Phenotypic data
  • Data download

Usage recommendations for probe PF-04554878 and control PF-00911705


In cells

Use at a concentration of 100 nM.

Use the recommended concentration to avoid off-target toxicity and/or off-target activity. Using concentrations that are higher than recommended could lead to false positive or confounding results.

In vivo

Tested in mice with oral administration. FAK phosphorylation inhibition (50%) was sustained in vivo for over 8 hours with a single oral dose of 30 mg/kg. No weight loss, morbidity or mortality was observed in any tumor growth inhibition experiment (up to 50 mg/kg BID x 17 days).